VASCULAR ACCESS SITE SCAR

This adverse event was reported 9 times

VASCULAR ACCESS SITE SCAR is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 GARADACIMAB 1 0.0013
1 LANADELUMAB-FLYO 3 0.0009
2 C1 ESTERASE INHIBITOR RECOMBINANT 2 0.0003
3 NORGESTIMATE AND ETHINYL ESTRADIOL 1 0.0002
4 DIMENHYDRINATE 2 0.0002
5 HUMAN C1-ESTERASE INHIBITOR 2 0.0001
6 ELEXACAFTOR, TEZACAFTOR, AND IVACAFTOR 1 0.0001
7 TEDUGLUTIDE 1 0.0001
8 ERGOCALCIFEROL 2 0.0001
9 AZELASTINE 1 0.0001
See all drugs enriched for association with VASCULAR ACCESS SITE SCAR

VASCULAR ACCESS SITE SCAR is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Plasma Kallikrein Inhibitor [EPC] 3 0.0013
1 Human C1 Esterase Inhibitor [EPC] 1 0.0003
2 GLP-2 Analog [EPC] 1 0.0001
3 Provitamin D2 Compound [EPC] 2 0.0001
4 Integrin Receptor Antagonist [EPC] 2 0.0000
5 Catecholamine [EPC] 1 0.0000
6 Anti-IgE [EPC] 1 0.0000
7 Serotonin Reuptake Inhibitor [EPC] 1 0.0000
8 Serotonin-3 Receptor Antagonist [EPC] 1 0.0000
9 Osmotic Laxative [EPC] 2 0.0000
See all drug classes enriched for association with VASCULAR ACCESS SITE SCAR